Modulight Oyj

Modulight Oyj FCF/Debt

The Free Cash Flow to Debt Ratio of Modulight Oyj (MODU.HE) as of Oct 22, 2026 is -217.09 %. In the previous year, Free Cash Flow to Debt Ratio was -128.42 % — a change of 69.05% (lower).

FCF/Debt

-217.09 %

YoY

69.05%

Last updated:

Free Cash Flow to Debt Ratio of Modulight Oyj is 2025 -217.09 % . Free Cash Flow to Debt Ratio of Modulight Oyj was 2024 -128.42 % . It decreases by 69.05% lower compared to the previous year.

The Modulight Oyj FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
17.61 EUR
Jan 1, 2019
-21.43 EUR
Jan 1, 2020
21.30 EUR
Jan 1, 2021
-149.77 EUR
Jan 1, 2022
-160.42 EUR
Jan 1, 2023
-351.06 EUR
Jan 1, 2024
-128.42 EUR
Jan 1, 2025
-217.09 EUR
The Modulight Oyj FCF/Debt history
YEARFCF/DebtYoY
-217.09 %+69.05%
-128.42 %-63.42%
-351.06 %+118.84%
-160.42 %+7.11%
-149.77 %-803.16%
21.30 %-199.40%
-21.43 %-221.66%
17.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Modulight Oyj Stock analysis

What does Modulight Oyj do? Modulight Oyj designs, markets, and manufactures semiconductor laser modules and other laser products, primarily serving biomedical applications in oncology, ophthalmology, and genetics. The company provides customized biomedical laser solutions, including wavelength, optical power, and beam engineering, leveraging its own fabrication plant and semiconductor process. Its subsidiaries include Modulight China Export A Oy, Leaptek Photonics Oy, and Modulight USA Inc., supporting global operations. The company generates revenue through direct sales of laser modules and customized solutions to medical device manufacturers and healthcare providers in the biomedical sector. Modulight Oyj focuses on high-precision laser technology for medical diagnostics and treatment, targeting segments such as oncology, ophthalmology, and genetics. Its products are sold under the Modulight brand, with subsidiaries facilitating international market access. The company’s revenue streams come from the sale of semiconductor laser modules and tailored biomedical laser solutions to clients in the medical and biomedical industries. The business model relies on in-house fabrication and semiconductor process capabilities to deliver specialized laser products. Modulight Oyj’s revenue is derived from selling laser modules and customized solutions to customers in the biomedical sector, including medical device manufacturers and healthcare providers. Subsidiaries like Modulight China Export A Oy and Modulight USA Inc. support regional sales and distribution. Modulight Oyj is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Modulight Oyj stock

Free Cash Flow to Debt Ratio of Modulight Oyj is -217.09 % in 2025.

Free Cash Flow to Debt Ratio of Modulight Oyj changed from -128.42 % to -217.09 %, representing a 69.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Modulight Oyj since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Modulight Oyj with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Modulight Oyj

All Key Metrics — Modulight Oyj